Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
group | 0.600 | None | 1.000 | 13 | 0 | 1996 | 2019 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.600 | None | 0.949 | 5 | 0 | 1990 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.560 | None | 1.000 | 3 | 0 | 1998 | 2009 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
group | 0.540 | None | 1.000 | 3 | 0 | 2005 | 2011 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.530 | None | 1.000 | 1 | 0 | 2002 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.500 | None | 0.969 | 18 | 0 | 1986 | 2019 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.400 | None | 1.000 | 11 | 0 | 1998 | 2017 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.400 | None | 0.950 | 10 | 0 | 1999 | 2019 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
group | 0.400 | None | 0.923 | 8 | 0 | 2003 | 2010 | ||||||||
|
cyclin dependent kinase inhibitor 1A | 0.403 | 0.769 | 1.9E-03 |
|
group | 0.400 | None | 1.000 | 8 | 0 | 2002 | 2010 | ||||||||
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
group | 0.400 | None | 0.947 | 6 | 0 | 1994 | 2017 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.400 | None | 1.000 | 6 | 0 | 1991 | 2018 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.400 | None | 0.971 | 3 | 0 | 1987 | 2018 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
group | 0.370 | None | 1.000 | 4 | 0 | 1997 | 2007 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
group | 0.370 | None | 1.000 | 4 | 0 | 2001 | 2011 | ||||||||
|
caudal type homeobox 2 | 0.458 | 0.769 | 0.53 |
|
group | 0.360 | None | 1.000 | 4 | 0 | 2001 | 2018 | ||||||||
|
thymidylate synthetase | 0.425 | 0.846 | 0.72 |
|
group | 0.360 | None | 1.000 | 2 | 0 | 1988 | 2008 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
group | 0.360 | None | 0.857 | 2 | 0 | 2008 | 2019 | ||||||||
|
SRC proto-oncogene, non-receptor tyrosine kinase | 0.467 | 0.885 | 1.00 |
|
group | 0.350 | None | 1.000 | 4 | 0 | 2003 | 2009 | ||||||||
|
prominin 1 | 0.410 | 0.846 | 1.9E-22 |
|
group | 0.350 | None | 1.000 | 3 | 0 | 2007 | 2015 | ||||||||
|
leucine rich repeat containing G protein-coupled receptor 5 | 0.542 | 0.654 | 2.5E-08 |
|
group | 0.350 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
group | 0.350 | None | 1.000 | 1 | 0 | 1992 | 2015 | ||||||||
|
TNF superfamily member 10 | 0.413 | 0.885 | 0.13 |
|
group | 0.350 | None | 1.000 | 1 | 0 | 2002 | 2015 | ||||||||
|
baculoviral IAP repeat containing 5 | 0.495 | 0.731 | 5.6E-02 |
|
group | 0.340 | None | 1.000 | 4 | 0 | 2004 | 2009 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.340 | None | 1.000 | 1 | 0 | 2000 | 2005 |